Renaissance Technologies’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,800
| Closed | -$229K | – | 3896 |
|
|
2024
Q3 | $229K | Sell |
15,800
-108,300
| -87% | -$1.57M | ﹤0.01% | 3078 |
|
|
2024
Q2 | $1.06M | Buy |
124,100
+111,500
| +885% | +$949K | ﹤0.01% | 2291 |
|
|
2024
Q1 | $129K | Sell |
12,600
-39,400
| -76% | -$403K | ﹤0.01% | 3323 |
|
|
2023
Q4 | $285K | Sell |
52,000
-85,700
| -62% | -$470K | ﹤0.01% | 3011 |
|
|
2023
Q3 | $521K | Sell |
137,700
-166,600
| -55% | -$630K | ﹤0.01% | 2693 |
|
|
2023
Q2 | $2.04M | Sell |
304,300
-26,300
| -8% | -$176K | ﹤0.01% | 1987 |
|
|
2023
Q1 | $2.15M | Buy |
330,600
+19,600
| +6% | +$128K | ﹤0.01% | 1986 |
|
|
2022
Q4 | $2.65M | Sell |
311,000
-3,400
| -1% | -$29K | ﹤0.01% | 1908 |
|
|
2022
Q3 | $1.66M | Sell |
314,400
-234,899
| -43% | -$1.24M | ﹤0.01% | 2144 |
|
|
2022
Q2 | $2.33M | Sell |
549,299
-121,243
| -18% | -$514K | ﹤0.01% | 2079 |
|
|
2022
Q1 | $2.35M | Buy |
670,542
+302,542
| +82% | +$1.06M | ﹤0.01% | 2120 |
|
|
2021
Q4 | $2.45M | Buy |
368,000
+251,400
| +216% | +$1.67M | ﹤0.01% | 1982 |
|
|
2021
Q3 | $1.16M | Buy |
+116,600
| New | +$1.16M | ﹤0.01% | 2466 |
|